Luyan Pharma Co.,Ltd. (SHE:002788)
China
· Delayed Price · Currency is CNY 15.03
+0.22 (1.49%)
Mar 10, 2026, 1:05 PM CST
Luyan Pharma Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 459.18 | 576.85 | 606.3 | 594.19 | 415.43 | 596.92 | Upgrade
|
| Cash & Short-Term Investments | 459.18 | 576.85 | 606.3 | 594.19 | 415.43 | 596.92 | Upgrade
|
| Cash Growth | -4.64% | -4.86% | 2.04% | 43.03% | -30.40% | 39.16% | Upgrade
|
| Accounts Receivable | 6,555 | 5,951 | 5,673 | 5,849 | 5,101 | 3,935 | Upgrade
|
| Other Receivables | 123.99 | 108.33 | 94.59 | 87.49 | 117.17 | 269.68 | Upgrade
|
| Receivables | 6,679 | 6,059 | 5,768 | 5,937 | 5,218 | 4,205 | Upgrade
|
| Inventory | 2,749 | 2,865 | 2,574 | 2,549 | 2,275 | 2,028 | Upgrade
|
| Prepaid Expenses | - | 0.02 | 0.25 | 0.33 | 0.08 | 0.25 | Upgrade
|
| Other Current Assets | 292.08 | 369.1 | 370.33 | 668.17 | 414.12 | 378.69 | Upgrade
|
| Total Current Assets | 10,180 | 9,870 | 9,319 | 9,748 | 8,322 | 7,209 | Upgrade
|
| Property, Plant & Equipment | 2,022 | 1,928 | 1,653 | 1,425 | 1,037 | 845.53 | Upgrade
|
| Long-Term Investments | 60.49 | 53.41 | 48.85 | 34.21 | 31.3 | 0.3 | Upgrade
|
| Goodwill | 289.28 | 289.28 | 288.65 | 289.45 | 289.45 | 283.88 | Upgrade
|
| Other Intangible Assets | 354.57 | 361.09 | 355.16 | 176.93 | 167.81 | 113.23 | Upgrade
|
| Long-Term Deferred Tax Assets | 81.61 | 75.79 | 66.37 | 54.71 | 43.39 | 35.11 | Upgrade
|
| Long-Term Deferred Charges | 25.04 | 29.04 | 28.58 | 28.96 | 32.82 | 33.73 | Upgrade
|
| Other Long-Term Assets | 29.14 | 31.5 | 34.46 | 26.08 | 68.98 | 50.73 | Upgrade
|
| Total Assets | 13,042 | 12,639 | 11,794 | 11,784 | 9,993 | 8,571 | Upgrade
|
| Accounts Payable | 4,304 | 4,004 | 3,444 | 3,258 | 2,410 | 2,006 | Upgrade
|
| Accrued Expenses | 51.67 | 86.74 | 98.53 | 119.54 | 111.6 | 103.73 | Upgrade
|
| Short-Term Debt | 4,037 | 3,875 | 3,990 | 4,455 | 4,130 | 3,362 | Upgrade
|
| Current Portion of Long-Term Debt | 533.71 | 293.91 | 171.26 | 58.25 | 47.31 | 21.31 | Upgrade
|
| Current Portion of Leases | - | 46.67 | 43.54 | 37.98 | 41.69 | - | Upgrade
|
| Current Income Taxes Payable | 54.9 | 36.67 | 43.98 | 43.47 | 45.42 | 44.26 | Upgrade
|
| Current Unearned Revenue | 27.19 | 30.72 | 22.38 | 31.78 | 10.57 | 18.73 | Upgrade
|
| Other Current Liabilities | 253.55 | 232.47 | 211.84 | 296.53 | 217.69 | 353.98 | Upgrade
|
| Total Current Liabilities | 9,263 | 8,605 | 8,026 | 8,301 | 7,015 | 5,910 | Upgrade
|
| Long-Term Debt | 344.35 | 648.41 | 578.63 | 475.04 | 226.6 | 116.94 | Upgrade
|
| Long-Term Leases | 89.07 | 87.33 | 74.33 | 53.86 | 40.37 | - | Upgrade
|
| Long-Term Unearned Revenue | 38.34 | 38.83 | 39.76 | 41.2 | 41.85 | 11.5 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 6.34 | 6.54 | 6.81 | 7.07 | 7.34 | 7.63 | Upgrade
|
| Other Long-Term Liabilities | 37.86 | 60.14 | 90.98 | 114.97 | 101.17 | 77.27 | Upgrade
|
| Total Liabilities | 9,779 | 9,447 | 8,817 | 8,993 | 7,433 | 6,124 | Upgrade
|
| Common Stock | 388.52 | 388.52 | 388.52 | 388.52 | 388.52 | 388.52 | Upgrade
|
| Additional Paid-In Capital | 611.87 | 617.54 | 631.05 | 653.6 | 656.37 | 752.07 | Upgrade
|
| Retained Earnings | 2,236 | 2,152 | 1,923 | 1,676 | 1,447 | 1,240 | Upgrade
|
| Comprehensive Income & Other | 4.04 | 4.24 | 3.84 | 2.82 | -0.5 | 0.49 | Upgrade
|
| Total Common Equity | 3,240 | 3,162 | 2,946 | 2,721 | 2,492 | 2,381 | Upgrade
|
| Minority Interest | 23.73 | 29.67 | 30.68 | 69.84 | 68.47 | 65.96 | Upgrade
|
| Shareholders' Equity | 3,264 | 3,192 | 2,977 | 2,791 | 2,560 | 2,447 | Upgrade
|
| Total Liabilities & Equity | 13,042 | 12,639 | 11,794 | 11,784 | 9,993 | 8,571 | Upgrade
|
| Total Debt | 5,004 | 4,951 | 4,858 | 5,080 | 4,486 | 3,500 | Upgrade
|
| Net Cash (Debt) | -4,545 | -4,374 | -4,252 | -4,486 | -4,071 | -2,903 | Upgrade
|
| Net Cash Per Share | -11.81 | -11.26 | -10.99 | -11.57 | -10.51 | -8.06 | Upgrade
|
| Filing Date Shares Outstanding | 388.52 | 388.52 | 388.52 | 388.52 | 388.52 | 388.52 | Upgrade
|
| Total Common Shares Outstanding | 388.52 | 388.52 | 388.52 | 388.52 | 388.52 | 388.52 | Upgrade
|
| Working Capital | 917.19 | 1,265 | 1,292 | 1,447 | 1,307 | 1,298 | Upgrade
|
| Book Value Per Share | 8.34 | 8.14 | 7.58 | 7.00 | 6.41 | 6.13 | Upgrade
|
| Tangible Book Value | 2,596 | 2,512 | 2,302 | 2,254 | 2,034 | 1,984 | Upgrade
|
| Tangible Book Value Per Share | 6.68 | 6.47 | 5.93 | 5.80 | 5.24 | 5.11 | Upgrade
|
| Buildings | - | 1,443 | 1,001 | 899.38 | 858.76 | 816.23 | Upgrade
|
| Machinery | - | 278.43 | 259.22 | 214.51 | 196.8 | 182.21 | Upgrade
|
| Construction In Progress | - | 471.48 | 616.59 | 509.06 | 139.74 | 57.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.